Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions
Loading...
Identifiers
Publication date
Advisors
Tutors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
The autoxidation and monoamine oxidase (MAO)-mediated metabolism of dopamine (3-hydroxytyramine; DA) cause a continuous production of hydroxyl radical (radical dotOH), which is further enhanced by the presence of iron (ferrous iron, Fe2+ and ferric ion, Fe3+). The accumulation of hydrogen peroxide (H2O2) in the presence of Fe2+ appears to discard the involvement of the Fenton reaction in this process. It has been found that the presence of DA significantly reduces the formation of thiobarbituric acid reagent substances (TBARS), which under physiological conditions takes place in mitochondrial preparations. The presence of DA is also able to reduce TBARS formation in mitochondrial preparations even in the presence of iron (Fe2+ and Fe3+). However, DA boosted the carbonyl content of mitochondrial proteins, which was further increased in the presence of iron (Fe2+ and Fe3+). This latter effect is also accompanied by a significant reduction in thiol content of mitochondrial proteins. It has also been observed how the pre-incubation of mitochondria with pargyline, an acetylenic MAO inhibitor, reduces the production of radical dotOH and increases the formation of TBARS. Although, the MAO-mediated metabolism of DA increases MAO-B activity, the presence of iron inhibits both MAO-A and MAO-B activities. Consequently, DA has been shown to be a double-edged sword, because it displays antioxidant properties in relation to both the Fenton reaction and lipid peroxidation and exhibits pro-oxidant properties by causing both generation radical dotOH and oxidation of mitochondrial proteins. Evidently, these pro-oxidant properties of DA help explain the long-term side effects derived from l-DOPA treatment of Parkinson’s disease and its exacerbation by the concomitant use of DA metabolism inhibitors.
Description
Bibliographic citation
Neurochemistry International, Volume 45, Issue 1, 2004, Pages 103-116
Relation
Has part
Has version
Is based on
Is part of
Is referenced by
Is version of
Requires
Sponsors
This study was supported by Grant BFI2003-00493 from the Ministerio de Ciencia y Tecnologı́a, Madrid (Spain).
Rights
CC BY-NC-ND








